Prasad 2004.

Methods	Setting: India, outpatient clinic; Design: parallel group; Length of intervention period: 12 weeks; Randomisation: alternate allocation (inadequate); Masking: double‐blind; Excluded: unclear; Withdrawals: stated; Baseline characteristics: comparable; Jadad score: 2
Participants	74 adults; age range: 12‐60. Inclusion criteria: asthma on the basis of clinical history and PFT; FEV1 <80% predicted (response to beta‐agonist <15%); night symptoms on 1/7 days; day symptoms on 3/7 days; Exclusion criteria: Patients taking oral/inhaled steroids for 1 month prior to study entry; smokers & unstable asthma
Interventions	FP 50 2 puffs BID (200mcg/d) BDP 100 2 puffs BID (400mcg/d) Inhaler device: MDI
Outcomes	FEV1; PEF; FEV1/FVC ratio; symptoms
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Adequate sequence generation?	High risk	Alternate allocation
Allocation concealment?	High risk	Not adequate
Blinding? All outcomes	Low risk	Identical inhaler devices